Table 1.
Clinical characteristics of 695 NPC.
| Characteristics | N (%) |
|---|---|
| Age | |
| Median: 45 yrs | |
| Range: 14–74 | |
| ≤45 yrs | 449 (64.6) |
| >45 yrs | 246 (35.4) |
| Gender | |
| Male | 540 (77.7) |
| Female | 155 (22.3) |
| Histopathology (WHO type) | |
| Type 1 | 40 (5.7) |
| Types 2.1 & 2.2 | 655 (94.3) |
| T-classification | |
| T1 | 43 (6.1) |
| T2 | 229 (32.9) |
| T3 | 244 (35.1) |
| T4 | 179 (25.9) |
| N-classification | |
| N0 | 49 (7.1) |
| N1 | 228 (32.8) |
| N2 | 383 (55.1) |
| N3 | 35 (5.0) |
| Clinical stage | |
| I | 43 (6.1) |
| II | 172 (24.7) |
| III | 268 (38.6) |
| IV | 212 (30.6) |
| Chemotherapy | |
| Not given | 236 (34.0) |
| Concurrent | 190 (27.3) |
| Induction + concurrent | 52 (7.5) |
| Concurrent + adjuvant | 217 (31.2) |